Literature DB >> 12782815

A murine model of cholesteatoma-induced bone resorption using autologous dermal implantation.

Holger Sudhoff1, Yvonne Liebehenz, Jessica Aschenbrenner, Jae Jung, Henning Hildmann, Stefan Dazert.   

Abstract

OBJECTIVE: To investigate a novel murine model for dermal implant-induced osteolysis analogous to bone resorption observed in middle ear cholesteatoma. STUDY
DESIGN: Animal experiment.
METHODS: We placed autologous dermal implants on the surface of mouse calvaria. The calvaria were examined at days 1, 3, 5, 7, and 14 after implantation by histological study and tartrate-resistant acid phosphatase immunohistochemical processing to detect osteoclasts.
RESULTS: Dermal implants showed a significantly increased osteoclast density compared with control samples. The dermal implant tissue remained viable and produced a robust, localized inflammatory osteolytic response on the adjacent calvarial surface. Osteoclasts were predominantly found on the surface of the calvarium with the greatest osteoclast density seen at 5 to 7 days after implantation.
CONCLUSION: The mouse model is expected to be a useful tool for investigating the pathogenesis of localized inflammatory bone resorption related to cholesteatoma.

Entities:  

Mesh:

Year:  2003        PMID: 12782815     DOI: 10.1097/00005537-200306000-00019

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

Review 1.  The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma.

Authors:  Shumin Xie; Xiaoli Wang; Jihao Ren; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-16       Impact factor: 2.503

2.  Progressive massive osteolysis secondary to benign squamous epithelial colonisation in chronic osteomyelitis.

Authors:  Radhesh K Lalam; Victor N Cassar-Pullicino; D Chas Mangham; Chas Mangham; Glen Clewer; Paul Cool
Journal:  Skeletal Radiol       Date:  2006-03-25       Impact factor: 2.199

Review 3.  Animal models of middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  J Biomed Biotechnol       Date:  2011-04-06

4.  TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation.

Authors:  Huaili Jiang; Yu Si; Zhuohao Li; Xi Huang; Suijun Chen; Yiqing Zheng; Guo Xu; Ximing Chen; Yubin Chen; Yi Liu; Hao Xiong; Qiuhong Huang; Maojin Liang; Zhigang Zhang
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

5.  Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS.

Authors:  Matthias Schürmann; Johannes F W Greiner; Verena Volland-Thurn; Felix Oppel; Christian Kaltschmidt; Holger Sudhoff; Barbara Kaltschmidt
Journal:  Cells       Date:  2020-01-14       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.